143 related articles for article (PubMed ID: 645949)
1. MAO activity, csf amine metabolites, and drug-free improvement in schizophrenia.
Van Kammen DP; Marder SR; Murphy DL; Bunney WE
Am J Psychiatry; 1978 May; 135(5):567-9. PubMed ID: 645949
[TBL] [Abstract][Full Text] [Related]
2. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia.
Bowers MB
Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448
[No Abstract] [Full Text] [Related]
3. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G
Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
[TBL] [Abstract][Full Text] [Related]
4. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
Rimón R; Roos BE; Kampman R; Hyyppä S; Ranta P; Myllylä V
Ann Clin Res; 1979 Feb; 11(1):25-9. PubMed ID: 453776
[TBL] [Abstract][Full Text] [Related]
5. Relationship between platelet MAO activity and concentrations of 5-HIAA and HVA in cerebrospinal fluid in chronic pain patients.
von Knorring L; Oreland L; Häggendal J; Magnusson T; Almay B; Johansson F
J Neural Transm; 1986; 66(1):37-46. PubMed ID: 2426397
[TBL] [Abstract][Full Text] [Related]
6. CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients.
Kirstein L; Bowers MB; Heninger G
Biol Psychiatry; 1976 Aug; 11(4):421-34. PubMed ID: 963133
[TBL] [Abstract][Full Text] [Related]
7. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
Leckman JF; Bowers MB; Sturges JS
Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid probenecid studies: a reinterpretation.
Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
[TBL] [Abstract][Full Text] [Related]
9. Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients.
Linnoila M; Ninan PT; Scheinin M; Waters RN; Chang WH; Bartko J; van Kammen DP
Arch Gen Psychiatry; 1983 Dec; 40(12):1290-4. PubMed ID: 6197036
[TBL] [Abstract][Full Text] [Related]
10. Genetic studies of CSF monoamine metabolites.
Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
[No Abstract] [Full Text] [Related]
11. Monoamine oxidase (MAO), 5-hydroxyindole acetic acid (5 HIAA) and homovanillic acid (HVA) in motor neuron disease.
Forsgren L; Almay BG; Häggendal J; Oreland L
Acta Neurol Scand; 1987 Jan; 75(1):22-7. PubMed ID: 2437756
[TBL] [Abstract][Full Text] [Related]
12. Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
Mann JJ; Stanley M; Neophytides A; de Leon MJ; Ferris SH; Gershon S
Neurobiol Aging; 1981; 2(1):57-60. PubMed ID: 7266742
[TBL] [Abstract][Full Text] [Related]
13. Early death and CSF monoamine metabolites in schizophrenia spectrum psychosis.
Carlborg A; Jokinen J; Nordström AL; Jönsson EG; Nordström P
Nord J Psychiatry; 2011 Apr; 65(2):101-5. PubMed ID: 20662686
[TBL] [Abstract][Full Text] [Related]
14. [Values of serial determinations of cerebrospinal fluid metabolites of biogenic amines in various neurologic diseases].
Spissu A; Piccardi MP; Corsini GU; Mangoni A
Acta Neurol (Napoli); 1976; 31(5):549-57. PubMed ID: 827925
[No Abstract] [Full Text] [Related]
15. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of chronic therapy-resistant schizophrenics before and after hemodialysis therapy.
Magnusson O; Fowler CJ; Ross SB; Schulman A; Wetterberg L
Artif Organs; 1983 Aug; 7(3):344-8. PubMed ID: 6194776
[TBL] [Abstract][Full Text] [Related]
16. Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history.
Lindström LH
Psychiatry Res; 1985 Apr; 14(4):265-73. PubMed ID: 2410940
[TBL] [Abstract][Full Text] [Related]
17. Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs.
Sedvall G; Fyrö B; Nybäck H; Wiesel FA; Wode-Helgodt B
J Psychiatr Res; 1974; 11():75-80. PubMed ID: 4461807
[No Abstract] [Full Text] [Related]
18. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
Sedvall G
Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
[TBL] [Abstract][Full Text] [Related]
19. [Monoamine metabolite levels in cerebrospinal fluid of schizophrenic patients].
Imazu Y; Kobayashi K; Kawabata M; Shohmori T
Seishin Shinkeigaku Zasshi; 1985; 87(9):634-42. PubMed ID: 2419935
[No Abstract] [Full Text] [Related]
20. Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction.
Stelmasiak Z
Neuropatol Pol; 1982; 20(1-2):97-105. PubMed ID: 6191248
[No Abstract] [Full Text] [Related]
[Next] [New Search]
